In fact, according to this article published in Psychiatric Times – the author Dr. John Miller – points out some glaring issues with cannabinoid research that needs to be addressed. I’ll be walking you through the basics of the article and focus in on his 10 suggestions for cannabinoid research.
Trulieve becomes the first U.S. cannabis company to trade on the NYSE on June 10.…
From robot canopy scanners to algorithmic breeders to AI-powered dispensary counters, artificial intelligence is remaking…
The latest version of this story comes from Virginia Commonwealth University, where researcher Emanuele Alves…
But there's more to this image than nostalgia and comedy. What you're looking at in…
The league pulled marijuana off its banned list in the new players’ agreement. In the…
In New South Wales, Australia, patients can legally use medical cannabis with a prescription. So…